Clinically shown to help manage IBS symptoms
Bifidobacterium longum PB-VIR™
Formerly known as PB-VIR™ Science
Originally derived from a healthy human gut1,2
Safe1,2
In a pre-clinical trial in influenza, a murine model showed that intra-nasal administration of the PB-VIR™ strain influenced host immune response1:
- Controlling viral numbers in the lungs at an earlier stage of infection than seen in the control group
- Stimulating a targeted immune response, without triggering the ‘cytokine storm’ and hyperinflammation that occurs when the host’s immune system overreacts to continuing high levels of infection
- Thereby reducing mortality and lung damage associated with influenza
Involves a unique mode of action that works at the site of administration e.g. the nasal cavity1
Learn more about the gut microbiome and immune health
Other Strains
Resource Centre
CPD e-learning
0.5 CPD learning hour
Clinical Summary
~4 minute read